• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by VSee Health Inc.

    10/8/24 4:15:54 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care
    Get the next $VSEE alert in real time by email
    S-8 1 tm2419985d6_s8.htm FORM S-8

     

    As filed with the Securities and Exchange Commission on October 8, 2024

     

    Registration No. 333-             

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

     

    FORM S-8

     

    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

     

     

    VSEE HEALTH, INC. 

    (Exact name of registrant as specified in its charter)

     

    Delaware
     
    (State or other jurisdiction of
    incorporation or organization)
      86-2970927
    (I.R.S. Employer
    Identification No.)

     

    VSee Health, Inc. 

    980 N Federal Hwy #304 

    Boca Raton, FL 33432 

    (Address of principal executive offices)

     

    (561) 672-7068 

    (Registrant’s telephone number, including area code)

     

     

    VSee Health, Inc. 2024 Equity Incentive Plan

    (Full title of the plan)

     

     Milton Chen and Imoigele Aisiku
    VSee Health, Inc.
    Co-Chief Executive Officers 
    980 N Federal Hwy #304
    Boca Raton, FL 33432
    (561) 672-7068
    (Name, address and telephone number of agent
    for service)
     
    Copies to: 
    Thomas J. Poletti, Esq.
    Veronica Lah, Esq.
    Manatt, Phelps & Phillips, LLP
    695 Town Center Drive, 14th Floor
    Costa Mesa, CA 92626
    Email: [email protected]
    Telephone: (714) 371-2501
     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

      Large accelerated filer ¨ Accelerated filer ¨
      Non-accelerated filer x Smaller reporting company x
          Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

     

     

     

    PART I

     

    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

     

    Item 1.Plan Information

     

    The documents containing the information specified in this Part I of Form S-8 will be sent or given to participants in the VSee Health, Inc. 2024 Equity Incentive Plan (the “Plan”) as specified by Rule 428(b)(1) under the Securities Act of 1933, as amended (the “Securities Act”).

     

    Such documents are not required to be, and are not, filed with the Securities and Exchange Commission (the “SEC”) either as part of this Registration Statement or as a prospectus or prospectus supplement pursuant to Rule 424 under the Securities Act. These documents and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II of Form S-8, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.

     

    Item 2.Registrant Information and Employee Plan Annual Information.

     

    VSee Health, Inc., a Delaware corporation (the “Company”) will furnish without charge to each person to whom the prospectus is delivered, upon the written or oral request of such person, a copy of any and all of the documents incorporated by reference into this Registration Statement pursuant to Item 3 of Part II hereof, other than exhibits to such documents (unless such exhibits are specifically incorporated by reference in such documents that are incorporated), and the other documents required to be delivered to eligible participants in the Plan pursuant to Rule 428(b) under the Securities Act. Requests should be directed to:

     

    VSee Health, Inc. 

    980 N Federal Hwy, Suite 340 

    Boca Raton, FL 33432 

    Attention: Corporate Secretary 

    Telephone: (561) 672-7068

     

     

     

     

    PART II

     

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    Item 3.Incorporation of Documents by Reference.

     

    The Registrant hereby incorporates by reference into this Registration Statement the following documents filed by it with the SEC:

     

    (a)The Registrant’s prospectus filed with the SEC on July 26, 2024 pursuant to Rule 424(b) under the Securities Act relating to the Registration Statement on Form S-1 (File No. 333-280845), which became effective on July 26, 2024 (the “S-1 Prospectus”), which contains the Company’s audited financial statements for the latest fiscal year for which such statements have been filed.
       
     (b)The Registrant’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2024 and June 30, 2024, filed with the SEC on May 15, 2024 and September 23, 2024, respectively.
       
     (c)The Registrant’s Current Reports on Form 8-K filed with the SEC on February 5, 2024, February 13, 2024, April 18, 2024, May 2, 2024, June 12, 2024, June 28, 2024, July 9, 2024, July 23, 2024, September 11, 2024, September 23, 2024, and October 1, 2024.
       
     (d)The description of the Registrant’s securities that is contained in the S-1 Prospectus, including any amendment or supplements thereto.

     

    All documents subsequently filed by the Registrant with the SEC pursuant to Sections 13(a), 13(c), 14, or 15(d) of the Exchange Act after the date hereof, and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed incorporated by reference into this Registration Statement and to be a part thereof from the date of the filing of such documents. Any statement contained in the documents incorporated, or deemed to be incorporated, by reference herein or therein shall be deemed to be modified or superseded for purposes of this Registration Statement and the prospectus to the extent that a statement contained herein or therein or in any other subsequently filed document which also is, or is deemed to be, incorporated by reference herein or therein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement and the prospectus.

     

    Under no circumstances shall any information furnished under Item 2.02 or 7.01 of Form 8-K be deemed incorporated herein by reference unless such Form 8-K expressly provides to the contrary.

     

    Item 4. Description of Securities

     

    Not applicable.

     

    Item 5. Interests of Named Experts and Counsel.

     

    Not applicable.

     

    Item 6. Indemnification of Directors and Officers.

     

    The Registrant is incorporated under the laws of the State of Delaware.

     

    The Registrant is governed by the Delaware General Corporation Law, as the same exists or may hereafter be amended (the “General Corporation Law”). Section 145 of the General Corporation Law (“Section 145”) provides that a Delaware corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of such corporation) by reason of the fact that such person is or was a director, officer, employee or agent of such corporation, or is or was serving at the request of such corporation as a director, officer, employee or agent of another corporation or enterprise. The indemnification may include expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding, provided such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation’s best interests and, with respect to any criminal action or proceeding, had no reasonable cause to believe that his conduct was unlawful. Section 145 also provides that a Delaware corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of such corporation, under the same conditions, except that such indemnification is limited to expenses (including attorneys’ fees) actually and reasonably incurred by such person, and except that no indemnification is permitted without judicial approval if such person is adjudged to be liable to such corporation. Where an officer or director of a corporation is successful, on the merits or otherwise, in the defense of any action, suit or proceeding referred to above, or any claim, issue or matter therein, the corporation must indemnify that person against the expenses (including attorneys’ fees) which such officer or director actually and reasonably incurred in connection therewith.

     

     

     

     

    Section 145 further authorizes a corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation or enterprise, against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person’s status as such, whether or not the corporation would otherwise have the power to indemnify such person against such liability under Section 145.

     

    The Registrant’s Second Amended and Restated Certificate of Incorporation provides that the Registrant has the power to provide rights to indemnification and advancement of expenses to its current and former officers, directors, employees and agents and to any person who is or was serving at the request of the Registrant as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise.

     

    The Registrant’s Amended and Restated Bylaws provide that the Registrant shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the Registrant) by reason of the fact that such person is or was a director or Registrant of the Registrant, or, while a director or officer of the Registrant, is or was serving at the request of the Registrant as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Registrant, and, with respect to any criminal action or proceeding, had no reasonable cause to believe such person’s conduct was unlawful. The Registrant shall not be obligated to indemnify any current or former director or officer in connection with an action, suit proceeding initiated by such person unless such action, suit or proceeding was authorized by the Board of Directors.

     

    The Registrant’s Second Amended and Restated Certificate of Incorporation provides that no director or officer of the Corporation shall have any personal liability to the Registrant or its stockholders for monetary damages for any breach of fiduciary duty as a director or officer, except to the extent such exemption from liability or limitation thereof is not permitted under the General Corporation Law. Pursuant to Section 102(b)(7) of the General Corporation Law, a corporation may eliminate the personal liability of a director to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liabilities arising (i) from any breach of the director’s duty of loyalty to the corporation or its stockholders, (ii) from acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law,(iii) under Section 174 of the General Corporation Law, or (iv) from any transaction from which the director derived an improper personal benefit.

     

    Indemnification Agreements

     

    The Registrant has entered into agreements with its directors providing indemnification of such directors by the Registrant to the fullest extent permitted by law, subject to certain limited exceptions. These agreements provide that the Registrant will indemnify each of our directors to the fullest extent permitted by Delaware law. The Registrant will advance all expenses incurred by the indemnified director (“Indemnitee”) in connection with any proceeding to which the Indemnitee is a party or is threatened to be made a party by reason of the fact that the Indemnitee is or was an agent of the Company or by reason of anything done or not done by the Indemnitee in any such capacity.

     

     

     

     

    Directors’ and Officers’ Liability Insurance

     

    The Registrant’s directors and executive officers are covered by insurance maintained by the Registrant against specified liabilities for actions taken in their capacities as such, including liabilities under the Securities Act.

     

    Item 7. Exemption From Registration Claimed.

     

    Not applicable.

     

    Item 8. Exhibits.

     

    Exhibit
    Number
       Description
    5.1   Opinion of Manatt, Phelps & Phillips LLP
         
    23.1   Consent of Manatt, Phelps & Phillips, LLP (contained in Exhibit 5.1)
         
    23.2   Consent of Withum Smith+Brown, PC, independent registered public accounting firm
         
    24.1   Power of Attorney (contained on signature page hereto)
         
    99.1   VSee Health, Inc. 2024 Equity Incentive Plan
         
    99.2   Form of Stock Option Agreement
         
    99.3   Form of Restricted Stock Unit Agreement
         
    99.4   Form of Restricted Stock Award Agreement
         
    107   Calculation of Filing Fee Table

     

    Item 9. Undertakings

     

    A. The undersigned Registrant hereby undertakes:

     

    (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

     

    (i) To include any prospectus required by section 10(a)(3) of the Securities Act;

     

    (ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

     

    (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.

     

     

     

     

    Provided, however, that paragraphs A(1)(i) and A(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to section 13 or section 15(d) of the Exchange Act that are incorporated by reference in the registration statement.

     

    (2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

     

    B. The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    C. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boca Raton, State of Florida, on October 8, 2024.

     

      VSEE HEALTH, INC.
       
      By: /s/ Imoigele Aisiku
      Name: Imoigele Aisiku
      Title: Co-Chief Executive Officer

     

    POWER OF ATTORNEY

     

    We, the undersigned officers and directors of VSee Health, Inc., do hereby constitute and appoint Milton Chen and Imoigele Aisiku, and each of them, as his/her true and lawful attorneys-in-fact and agents, with full power of substitution for him in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Name and Signature   Title   Date
             
     /s/ Milton Chen   Co-Chief Executive Officer and Director
    (Principal Executive Officer)
      October 8, 2024
     Milton Chen      
             
    /s/ Imoigele Aisiku  

    Co-Chief Executive Officer, Chairman, Director

    (Principal Executive Officer)

      October 8, 2024
    Imoigele Aisiku      
             
    /s/ Jerry Leonard  

    Chief Financial Officer and Secretary

    (Principal Financial and Accounting Officer)

      October 8, 2024
    Jerry Leonard      
             
    /s/ Kevin Lowdermilk   Director   October 8, 2024
    Kevin Lowdermilk        
             
    /s/ Colin O’Sullivan   Director   October 8, 2024
    Colin O’Sullivan        
             
    /s/ Scott Metzger   Director   October 8, 2024
    Scott Metzger        
             
    /s/ Cydonii V. Fairfax   Director   October 8, 2024
    Cydonii V. Fairfax        
             
    /s/ David L. Wickersham   Director   October 8, 2024
    David L. Wickersham        

      

     

    Get the next $VSEE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VSEE

    DatePrice TargetRatingAnalyst
    2/24/2025$5.00Buy
    Maxim Group
    More analyst ratings

    $VSEE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wickersham David L. was granted 68,397 shares, decreasing direct ownership by 14% to 224,067 units (SEC Form 4)

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    1/16/26 5:01:38 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Director Metzger Scott was granted 68,624 shares, decreasing direct ownership by 84% to 8,852 units (SEC Form 4)

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    1/16/26 5:01:18 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Director Lowdermilk Kevin was granted 68,624 shares, decreasing direct ownership by 100% to 227 units (SEC Form 4)

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    1/16/26 5:00:47 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Financials

    Live finance-specific insights

    View All

    VSee Health Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / December 20, 2024 / RedChip Companies will air an interview with VSee Health, Inc. (NASDAQ:VSEE) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, December 21, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interview in its entirety at: https://www.redchip.com/assets/access/vsee_accessIn an exclusive interview, Milton Chen, PhD, co-CEO of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated solutions position the company as a growing leader in the $787 billion telehealth

    12/20/24 9:00:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health and 60 Degrees Pharmaceuticals Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / December 2, 2024 / RedChip Companies aired interviews with VSee Health, Inc. (NASDAQ:VSEE) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV on November 30. Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:VSEE: https://www.redchip.com/assets/access/vsee_accessSXTP: https://www.redchip.com/assets/access/sxtp_accessIn an exclusive interview, Imo Aisiku, M.D., co-CEO and Chairman of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated so

    12/2/24 4:05:00 PM ET
    $SXTP
    $VSEE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Nursing Services

    $VSEE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on VSee Lab with a new price target

    Maxim Group initiated coverage of VSee Lab with a rating of Buy and set a new price target of $5.00

    2/24/25 8:42:03 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911

    VSee Health, Inc. (NASDAQ:VSEE) a leading provider of secure digital health solutions, today announced the launch of its new AI doctor notes, one of the solutions in its AI solutions suite. VSee has partnered with Tele911, the largest national telemedicine emergency room diversion service, to integrate VSee's AI Doctor Notes into its virtual emergency care workflow. Emergency medicine demands rapid decision-making and high patient throughput. The integration has drastically reduced Tele911 physician's charting time by 93% from 15 minutes per visit to under 1 minute, potentially increasing physician visit capacity. This new VSee AI solution automatically transcribes visits and generates

    7/14/25 8:17:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial

    VSee Health, Inc. (NASDAQ:VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial study on stroke recovery telerehabilitation based out of UCLA—the second such national trial of post-stroke telerehabilitation. The trial spans 29 hospitals and 202 patients, and will evaluate the outcomes of adding 6 weeks of gamified, home-based telerehab to improve arm functionality in stroke survivors while reducing costs like transportation, caregiver burdens, and hospital readmissions. The proven efficacy of Phase 3 trials opens doors for Medicare and private payer reimbursement and opportunities in the $328M global stroke re

    6/23/25 8:27:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q Filing

    VSee Health, Inc. (the "Company") (NASDAQ:VSEE), announced today that on May 23, 2025, the Company received a notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2025, and its Annual Report on Form 10-K for the period ended December 31, 2024, the Company is not in compliance with Nasdaq's listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the "SEC"). The Nasdaq notice has no immediate effect on the listing or trading of the Company's common stock or its public warrants on The Nasdaq Capital Market.

    5/30/25 4:07:00 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    SEC Filings

    View All

    SEC Form DEF 14A filed by VSee Health Inc.

    DEF 14A - VSEE HEALTH, INC. (0001864531) (Filer)

    2/5/26 10:15:58 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by VSee Health Inc.

    SCHEDULE 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

    2/3/26 12:58:16 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    SEC Form PRE 14A filed by VSee Health Inc.

    PRE 14A - VSEE HEALTH, INC. (0001864531) (Filer)

    1/26/26 5:11:43 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by VSee Health Inc.

    SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

    11/14/24 8:45:14 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by VSee Health Inc.

    SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

    11/14/24 5:23:34 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by VSee Health Inc.

    SC 13G - VSEE HEALTH, INC. (0001864531) (Subject)

    7/5/24 4:29:01 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care